A phase I microplaque study of XCUR17 in patients with mild to moderate psoriasis

Trial Profile

A phase I microplaque study of XCUR17 in patients with mild to moderate psoriasis

Planning
Phase of Trial: Phase I

Latest Information Update: 15 Mar 2018

At a glance

  • Drugs XCUR 17 (Primary)
  • Indications Psoriasis
  • Focus Adverse reactions
  • Most Recent Events

    • 15 Mar 2018 New trial record
    • 09 Mar 2018 According to an Exicure media release, the German regulatory authority has approved the application for this trial. The company expects the first patient to be dosed in early 2018 and expects the clinical trial to be completed in mid-2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top